COVID-19 and FTD

AFTD Resources

Expert Letters

Throughout the pandemic, healthcare experts, including members of AFTD’s Medical Advisory Committee, are contributing open letters addressing specific aspects of managing FTD care during the time of COVID-19:

March 17, 2020
A Message from Dr. Murray Grossman about COVID-19

Murray Grossman, MDCM, AFTD Medical Advisory Council

March 23, 2020
Primary Progressive Aphasia and COVID-19

Marsel Mesulam, MD, AFTD Medical Advisory Council

April 13, 2020
Handling COVID’s Unique Challenges for People with FTD and ALS/FTD

Beth K. Rush, PhD, ABPP, Mayo Clinic Florida

April 24, 2020
Lowering the Risk of COVID-19 While Living with FTD

Irene Litvan, MD, FAAN, FANA, AFTD Medical Advisory Council

May 8, 2020
FTD Care During the COVID-19 Pandemic: Challenges and Suggestions

Ted Huey, MD, AFTD Medical Advisory Council

June 1, 2020
Navigating FTD Long-Term Care During the COVID-19 Pandemic

Carmela Tartaglia, MD, FRCPC, University of Toronto

August 24, 2020
FTD Caregiving in a Pandemic

Darby J Morhardt, PhD, LCSW, Northwestern University

September 2, 2020
FTD Research and Clinical Trials during the COVID-19 Pandemic

Elizabeth Finger, MD, University of Western Ontario

February 26, 2021
COVID-19: Navigating Risk for People with FTD and their Families

Susan L-J Dickinson, AFTD CEO

Sign Up with AFTD

color-icon-laptop

Stay on top of the latest FTD news and AFTD events.